Posts

Engineering alternative butanol production platforms in heterologous bacteria.

Nielsen DR, Leonard E, Yoon S-H, Tseng H-C, Yuan C, Prather KLJones.  2009.  Engineering alternative butanol production platforms in heterologous bacteria. Metab Eng. 11(4-5):262-73. Google Scholar PubMed

Metabolic engineering of Escherichia coli for enhanced production of (R)- and (S)-3-hydroxybutyrate.

Tseng H-C, Martin CH, Nielsen DR, Prather KLJones.  2009.  Metabolic engineering of Escherichia coli for enhanced production of (R)- and (S)-3-hydroxybutyrate. Appl Environ Microbiol. 75(10):3137-45. Google Scholar PubMed

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.

Lu TK, Collins JJ.  2009.  Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A. 106(12):4629-34. Google Scholar PubMed

Engineering microbes with synthetic biology frameworks.

Leonard E, Nielsen D, Solomon K, Prather KJones.  2008.  Engineering microbes with synthetic biology frameworks. Trends Biotechnol. 26(12):674-81. Google Scholar PubMed

De novo biosynthetic pathways: rational design of microbial chemical factories.

Prather KLJones, Martin CH.  2008.  De novo biosynthetic pathways: rational design of microbial chemical factories. Curr Opin Biotechnol. 19(5):468-74. Google Scholar PubMed

Metabolic engineering of a novel propionate-independent pathway for the production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in recombinant Salmonella enterica serovar typhimurium.

Aldor IS, Kim S-W, Prather KLJones, Keasling JD.  2002.  Metabolic engineering of a novel propionate-independent pathway for the production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in recombinant Salmonella enterica serovar typhimurium. Appl Environ Microbiol. 68(8):3848-54. Google Scholar PubMed